glioblastoma
Showing NaN - NaN of 26
Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)
Recruiting
- Glioblastoma
- Concurrent CRT Period
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Johns Hopkins Hospital
Mar 2, 2023
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Brain Tumor Trial in Baltimore, Rochester (Exablate Model 4000)
Recruiting
- Glioblastoma
- +2 more
- Focused Ultrasound (Exablate Model 4000)
-
Miami, Florida
- +5 more
Jan 18, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)
Recruiting
- Glioblastoma
- +3 more
- Procedure: LITT
- Hypo-Fractionated Radiation Therapy
-
Baltimore, Maryland
- +3 more
Oct 10, 2022
Glioma, Glioblastoma Trial in United States (Focused ultrasound (FUS))
Active, not recruiting
- Glioma
- Glioblastoma
- Focused ultrasound (FUS)
-
Baltimore, Maryland
- +3 more
Sep 8, 2022
Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
-
Costa Mesa, California
- +49 more
Aug 24, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)
Recruiting
- Glioblastoma
- +5 more
- Ipilimumab
- +4 more
-
Birmingham, Alabama
- +19 more
Aug 16, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Glioma, Glioblastoma, Brain Tumor Trial in United States (LITT, Hypofractionated Radiation Therapy)
Recruiting
- Glioma
- +2 more
- LITT
- Hypofractionated Radiation Therapy
-
Baltimore, Maryland
- +4 more
Apr 26, 2022
Glioblastoma, Gliosarcoma Trial in Miami, Atlanta, Baltimore (radiation, procedure, drug)
Active, not recruiting
- Glioblastoma
- Gliosarcoma
- Dose-Escalated Radiation Therapy
- +2 more
-
Miami, Florida
- +2 more
Feb 16, 2022
Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)
Not yet recruiting
- Glioblastoma
-
Baltimore, MarylandJohns Hopkins University
Dec 10, 2021
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor
Terminated
- Glioblastoma
- Glioblastoma Multiforme
- Nivolumab
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020
Glioblastoma, Astrocytoma, Grade IV Trial in Baltimore, New York (EGFR(V)-EDV-Dox)
Unknown status
- Glioblastoma
- Astrocytoma, Grade IV
-
Baltimore, Maryland
- +1 more
Aug 27, 2019
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,
Completed
- Glioblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Mobile, Alabama
- +329 more
Jul 22, 2019
Glioblastoma Trial in Baltimore (Lymphocyte harvesting & reinfusion)
Completed
- Glioblastoma
- Lymphocyte harvesting & reinfusion
-
Baltimore, MarylandJohns Hopkins University
Nov 5, 2018
Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,
Completed
- Glioblastoma
- +4 more
- Rindopepimut (CDX-110) with GM-CSF
- +2 more
-
Birmingham, Alabama
- +222 more
Jan 11, 2018
Glioblastoma, Anaplastic Astrocytoma Trial in Baltimore (Fingolimod)
Completed
- Glioblastoma
- Anaplastic Astrocytoma
-
Baltimore, MarylandThe Johns Hopkins University
Sep 12, 2017